Purchases and Sales Made in Q4 2023 in Effector Therapeutics Inc (EFTRW)
This table provides information about the institutional ownership of Effector Therapeutics Inc (EFTRW) during Q4 2023. The information is specifically focused on institutions that hold shares of EFFECTOR THERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
1.43KNew |
$100 - $272
|
1.43K
$0
|
|
|
Mar 01, 2024
Q4 2023
|
Pineridge Advisors LLC
St. Charles, MO |
BUY
|
- |
33New |
$2.31 - $6.27
|
33
$0
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Aristeia Capital LLC
Greenwich, CT |
SELL
|
- |
-100- 0.01% |
$7 - $19
|
1.49M
$0
|
|
|
Feb 01, 2024
Q4 2023
|
Wolverine Asset Management LLC
|
SELL
|
- |
-1.02K- 5.45% |
$71.2 - $193
|
17.6K
$0
|